Tyers Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Tyers Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$348K	Hold	5,611	–	–	0.01%	571
2019 Q2	$400K	Buy	5,611 +539	+11%	+$39.7K	0.01%	536
2019 Q1	$398K	Hold	5,072	–	–	0.01%	529
2018 Q4	$429K	Hold	5,072	–	–	0.02%	451
2018 Q3	$869K	Buy	5,072 +135	+3%	+$20.4K	0.03%	326
2018 Q2	$638K	Hold	4,937	–	–	0.02%	385
2018 Q1	$509K	Hold	4,937	–	–	0.02%	409
2017 Q4	$422K	Buy	4,937 +1,077	+28%	+$93.3K	0.01%	474
2017 Q3	$328K	Buy	3,860 +763	+25%	+$60.4K	0.01%	505
2017 Q2	$235K	Buy	3,097 +1,436	+86%	+$100K	0.01%	570
2017 Q1	$110K	Buy	1,661 +314	+23%	+$20.7K	﹤0.01%	646
2016 Q4	$85K	Buy	+1,347	New	+$85K	﹤0.01%	679

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Tyers Asset Management's LGND Position: Q3 2019 in Review

Tyers Asset Management held its Ligand Pharmaceuticals (LGND) position steady in Q3 2019 at 5,611 shares worth $348K. The position accounts for 0.01% of the portfolio, ranked #571.

Tyers Asset Management first reported a position in LGND in Q4 2016 and has held it in 12 quarters since. The position peaked at $869K in Q3 2018. 275 funds tracked by Wall St. Rank hold LGND as of Q3 2019.

Tyers Asset Management held 5,611 shares of Ligand Pharmaceuticals worth $348K as of Q3 2019.
Tyers Asset Management left its Ligand Pharmaceuticals share count unchanged in Q3 2019.
Ligand Pharmaceuticals made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #571 holding.
Tyers Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's Ligand Pharmaceuticals position peaked at $869K in Q3 2018.
275 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.